Stock Price
1,853.50
Daily Change
62.00 3.46%
Monthly
-11.23%
Yearly
17.09%
Q1 Forecast
1,757.86

Genmab reported DKK34.31 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07 2025
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08 2025
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12 2025
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06 2024
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08 2024




Eps Change Date
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Almirall EUR 0.1 0.06 Jun/2025
Amarin USD 0.08 0.11 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
argenx SE USD 4.44 1.18 Sep/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Demant DKK 6.1 0.5 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Fresenius Medical Care EUR 1.1 0.19 Sep/2025
Galapagos EUR -0.41 0.16 Sep/2025
Genmab DKK 34.31 14.07 Jun/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
GN Store Nord DKK 2.51 2.01 Dec/2025
GRIFOLS EUR 0.21 0.02 Sep/2025
Hikma Pharmaceutical USD 0.54 0.06 Jun/2025
Insmed USD -1.54 0.21 Dec/2025
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.32 0.56 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
UCB EUR 2.44 0.45 Jun/2025